Dr. Bruce Montgomery serves as Chief Executive Officer and Board Member at Avalyn. Prior to Avalyn, Dr. Montgomery was a Co-Founder and served as the Chief Executive Officer & Board Member at Cardeas Pharma. He also served as Board Member at Athira Pharma. He also serves as an Investment Committee Member at The W Fund. He serves as Chief Executive Officer at Life Sciences Discovery Fund. He previously held the position of Senior Vice President, Respiratory Therapeutics at Gilead Sciences, Inc. Before his work with Gilead, Dr. Montgomery was the Founder and CEO of Corus Pharma of Seattle, a drug development company focusing on infectious disease and respiratory drugs. Corus Pharma was purchased by Gilead Sciences, Inc. in August of 2006. Until October 2000, Dr. Montgomery served as Executive Vice President of Research and Development at PathoGenesis Corporation. He has extensive pharmaceutical company experience in drug development, operations and financing. He received his B.S. in Chemistry (Magna cum Laude, Outstanding Chemistry Major [Merck Award]), and M.D. (Alpha Omega Alpha Honor Medical Society) from the University of Washington, Seattle. He is a board certified internist and pulmonologist.